A lie is a lie no matter how many times you tell it

  • by: |
  • 03/10/2006

On February 23, Bob Goldberg blogged on the half-truths Liberally sprinkled throughout a report issued by the Democrat minority staff of the House Government Reform Committee. Dr. Goldberg’s argument was based 100% on fact. The report by the minority staff was based on politics, sound bites, and fuzzy math. As my grandmother used to say, a half truth is a whole lie.

Now it seems that Democrats in Congress are taking the same half-truth strategy, customizing its fallacies to fit local constituencies and taking it on the road. Consider the case of Northern California.

Here’s how the San Francisco Chronicle reported it …

Bay Area Democrats in Congress released a survey earlier this week concluding that prices for 10 top-selling drugs purchased through Medicare were higher than those paid by Canadian consumers or Costco customers … For its part, the study by Bay Area Democrats found the average costs of 10 common brand-name drugs offered by 10 plans in the Bay Area were 75 percent higher than prices negotiated by the federal government for agencies such as the Veterans’ Administration, 60 percent higher than prices in Canada, nearly 5 percent higher than prices available online through Drugstore.com and almost 2 percent higher than those at warehouse club retailer Costco.

Yep — it’s the exact same story that ran in the national press in late February. How soon the media forgets. And I fear it is selective memory loss.

So let me repeat what Bob said only a few short weeks ago — the Bay Area Dems deliberately omitted drug plans that allow patients to pay a fixed low price for all the drugs they survey. There are many drug plans that allow consumers to pay $30 for a month’s supply of each drug (or $25 a month if purchased through mail order). All these prices are substantially lower than any of the average prices cited by the Democrat staff. Not decimal dust.

Maybe we should call these representatives the new Bay City Rollers.


Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog